Parkinson's disease: Latest News, Top Stories & Analysis - Page 2 of 2

MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has made strides in the fight against neurodegenerative diseases with the filing of three new patents. These cover novel combination therapies involving their …

Medical Products

Annovis Bio Gains FDA Approval for New Form of Neurodegenerative Drug

July 17, 2024July 16, 2024 - by Timothy Alexander

MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has received approval from the U.S. Food and Drug Administration (FDA) to transition to a new solid form of buntanetap in future …

Parkinson’s disease

Annovis Bio Files Patents for Innovative Therapies in Neurodegenerative Disease Treatment

Annovis Bio Gains FDA Approval for New Form of Neurodegenerative Drug